Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: A systematic review and meta-analysis

被引:25
|
作者
Alemu, Ayinalem [1 ]
Bitew, Zebenay Workneh [2 ]
Worku, Teshager [3 ]
机构
[1] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia
[2] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia
[3] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia
关键词
Drug-resistant; Ethiopia; Multi-drug resistant tuberculosis; TREATMENT SUCCESS; RISK-FACTORS; MORTALITY; SURVIVAL; TB; CARE; COHORT; DEATH;
D O I
10.1016/j.ijid.2020.05.087
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To assess poor treatment outcomes and their predictors among drug-resistant tuberculosis patients treated in Ethiopia. Methods: Data were searched from both electronic databases and other sources. From the whole search, 404 articles were reviewed and 17 articles that fulfilled the inclusion criteria were included in the analysis. Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed and Joanna Briggs Institute Critical Appraisal checklist was used for assessing the quality. Risk of bias was assessed using forest plot and Egger's regression test. Data were analyzed using STATA version 15 and Review Manager Software version 5.3. Results: The overall pooled proportion of poor treatment outcome and mortality was 17.86% and 15.13% respectively. The incidence density rate of poor treatment outcome and mortality was 10.41/1000 person-months and 9.28/1000 person-months respectively. Survival status and successful treatment outcomes were 76.97% and 63.82% respectively. HIV positivity, non-HIV comorbidities, clinical complications, extrapulmonary involvement, undernutrition, anemia, treatment delay, lower body weight, and older age were the predictors of poor treatment outcome. Conclusion: Better survival and treatment success rates were noted in Ethiopia as compared to the global average. The majority of the poor treatment outcomes occurred within the intensive phase. Early initiation of anti-tuberculosis treatment would be important for successful treatment outcomes. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:420 / 439
页数:20
相关论文
共 50 条
  • [21] Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis
    Wenlu, Yang
    Xia, Zhao
    Chuntao, Wu
    Qiaolin, Yu
    Xujue, Xiao
    Rong, Yao
    Dan, Su
    Xi, Yan
    Bin, Wan
    [J]. BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [22] Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis
    Yang Wenlu
    Zhao Xia
    Wu Chuntao
    Yu Qiaolin
    Xiao Xujue
    Yao Rong
    Su Dan
    Yan Xi
    Wan Bin
    [J]. BMC Infectious Diseases, 24
  • [23] Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study
    Daniel Bekele Ketema
    Kindie Fentahun Muchie
    Asrat Atsedeweyn Andargie
    [J]. BMC Public Health, 19
  • [24] Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis
    Guisheng Xu
    Xiaojiang Hu
    Yanshu Lian
    Xiuting Li
    [J]. BMC Infectious Diseases, 23
  • [25] Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study
    Ketema, Daniel Bekele
    Muchie, Kindie Fentahun
    Andargie, Asrat Atsedeweyn
    [J]. BMC PUBLIC HEALTH, 2019, 19 (01)
  • [26] Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis
    Wen, Shuqin
    Yin, Jia
    Sun, Qiang
    [J]. BMJ OPEN, 2020, 10 (10):
  • [27] Baseline and Treatment Emergent Bedaquiline Resistance in Drug-resistant Tuberculosis: A Systematic Review and Meta-analysis
    Perumal, R.
    Bionghi, N.
    Nimmo, C.
    Cummings, M. J.
    Hopson, M.
    Wolf, A.
    Larsen, M.
    O'Donnell, M. R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [28] Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis
    Xu, Guisheng
    Hu, Xiaojiang
    Lian, Yanshu
    Li, Xiuting
    [J]. BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [29] Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis
    Pedersen, Ole Skouvig
    Holmgaard, Freja Breth
    Mikkelsen, Mads Kristian Duborg
    Lange, Christoph
    Sotgiu, Giovanni
    Lillebaek, Troels
    Andersen, Aase Bengaard
    Wejse, Christian Morberg
    Dahl, Victor Naestholt
    [J]. JOURNAL OF INFECTION, 2023, 87 (03) : 177 - 189
  • [30] Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis
    Alemu, Ayinalem
    Bitew, Zebenay Workneh
    Diriba, Getu
    Seid, Getachew
    Moga, Shewki
    Abdella, Saro
    Gashu, Emebet
    Eshetu, Kirubel
    Tollera, Getachew
    Dangisso, Mesay Hailu
    Gumi, Balako
    [J]. PLOS ONE, 2023, 18 (07):